Publication Name	World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID	19687
Country	Greece

Received	2015-05-17 18:45
Peer-Review Started	2015-05-18 09:58
First Decision by Editorial Office Director
Return for Revision	2015-06-24 19:59
Revised	2015-07-05 19:22
Publication Fee Transferred
Second Decision by Editor	2015-07-21 19:40
Second Decision by Editor-in-Chief	2015-07-21 23:03
Final Decision by Editorial Office Director	2015-08-03 15:41
Articles in Press	2015-08-03 15:41
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-10-23 19:08
Publish the Manuscript Online	2015-11-12 18:51

ISSN	2150-5349 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Pharmaceutical management of hepatitis B and C in liver and kidney transplant recipients
Manuscript Source	Invited Manuscript
All Author List	Chrysoula Pipili and Evangelos Cholongitas
Funding Agency and Grant Number
Corresponding Author	Evangelos Cholongitas, Assistant Professor of Internal Medicine, 4th Department of Internal Medicine, Medical School of Aristotle University, Hippokration General Hospital of Thessaloniki, 49, Konstantinopoleos Street, 54642 Thessaloniki, Greece. cholongitas@yahoo.gr
Key Words	Viral hepatitis; Hepatitis B; Hepatitis C; Liver transplantation; Kidney transplantation hepatitis B recurrence; Hepatitis C recurrence
Core Tip	Emphasis should be placed in the appropriate nucleo(s)tide analog selection for prevention of recurrent hepatitis B virus post liver and kidney transplantation; Second generation direct acting oral antivirals have demonstrated sustained virological response rates approaching 100%, minimal side effects and drug interactions on liver transplant recipients with chronic hepatitis C virus (HCV); Preliminary data showed outstanding response of kidney transplant recipients with chronic HCV to direct acting oral antivirals.
Publish Date	2015-11-12 18:51
Citation	Pipili C, Cholongitas E. Pharmaceutical management of hepatitis B and C in liver and kidney transplant recipients. World J Gastrointest Pharmacol Ther 2015; 6(4): 105-110
URL	http://www.wjgnet.com/2150-5349/full/v6/i4/105.htm
DOI	http://dx.doi.org/10.4292/wjgpt.v6.i4.105

Full Article (PDF)	WJGPT-6-105.pdf
Full Article (Word)	WJGPT-6-105.doc
Manuscript File	19687-Review.doc
Answering Reviewers	19687-Answering reviewers.pdf
Audio Core Tip	19687-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	19687-Conflict-of-interest statement.pdf
Copyright License Agreement	19687-Copyright assignment.pdf
Peer-review Report	19687-Peer-review(s) .pdf
Journal Editor-in-Chief Review Report	19687-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	19687-Scientific misconduct check.pdf
Scientific Editor Work List	19687-Scientific editor work list.pdf